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STUDIES ON THE NATURE OF SÜSŒPTIBILITY AND RESISTANŒ 
TO WALKER-256 CARCINOSARCOMA IN RATS
CHAPTER I 
HISTORY AND INTRODUCTION
Investigators in the field of experimental cancer research all 
seem to agree that one of the outstanding effects of tumor transplantation 
on the host is a lowered activity of liver catalase. This observation 
was first made by Rosenthal (1912) in mice and by Brahn (1916) in cancer­
ous patients. Since 1941 this phenomenon has been confirmed repeatedly 
by many investigators using different types of tumor and hosts.
Greenstein, Jenrette, and White (1941) found that rats carrying 
Hepatic Tumor #31 have one-tenth as much liver catalase as normal animals. 
Greenstein and Andervont (1942) also studying different strains of mice 
with spontaneous, methylcholanthrene-induced sarcoma, and many trans­
plants of tumor tissues found that the decrease in liver catalase was 
progressive with the growth of the tumor. The slow-growing tumors did 
not show this phenomenon. They also found that in case of tumor regres­
sion or extirpation of the tumor mass, catalase returns to normal values.
Greenstein, Andervont, and Thompson, (1942) studied the effect 
of Hepatoma 31 and Jensen sarcoma on 0sbome-Mende1 and Buffalo rats 
and also studied some systemio effects of transplanted and spontaneous
2
tumors on different strains of mice. Tney found that kidney catalase of 
tumor-bearing rats and mice became slightly reduced. Kidney catalase of 
normal mice is but one-half that of the livers of this species while kid­
ney catalase of normal rats is only slightly less than their liver cata­
lase. Erythrocyte catalase of tumor-bearing animals was unchanged in 
spite of low red blood cell count and hemoglobin concentration.
Weil-Malherbe and Schade (1948) studied the effect of Jensen 
sarcoma on rats and found that the tumor growth caused lowering of the 
liver catalase in the host. In extreme cases this reduction reached 5 
per cent of the normal value. These same authors studied the effects of 
two non-specific proteins, sheep serum and peptone on catalase concentra­
tion. They found that an injection of sheep serum 11 days after inocula­
tion with tumor caused no inhibition of tumor growth or change in liver 
catalase concentration whereas an injection of sheep serum 4 days after 
tumor transplantation caused a slight inhibition of the tumor growth. 
Injection of sheep serum into normal rats caused increased liver cata­
lase activity with no change in protein concentration of liver extract. 
Peptone was without effect.
Adams (1950) investigated the effect of subcutaneous growth of 
sarcoma 37 and of carcinoma 63 in two strains of mice. He showed that 
normal males, usually possessing higher liver catalase than normal 
females are more sensitive to the liver catalase reduction response than 
females when injected with the tumor.
Appleman et̂  (1950) using a subcutaneous methylcholanthrene- 
induced active fibrosarcoma and Jensen rst sarcoma in adult rats of both 
sexes found that both of these tumors oroduced a reduction in liver
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catalase activity to about 20 per cent of normal in the tumor-bearing 
rats, while kidney and erythrocyte catalase did not change significantly.
Begg (1951) studied the systemic effects of the solid form of 
Walker-256 carcinoma and Jensen sarcoma on young male rats. Among other 
effects, he found that lowering of liver catalase was progressive with 
the tumor growth, and was reduced to 48 per cent of the normal value when 
the tumor was 40 mm in size. Decreases in adrenal ascorbic acid and 
cholesterol, low hemoglobin concentration, and increased weight of liver 
were other systemic effects of these tumors reported by Begg.
Hargreaves and Deutsch (1952) reported the effects of Jensen 
rat sarcoma on male and female rats and found that liver catalase is 
reduced to 60 per cent of the normal value in males and to 35 per cent of 
normal in the female host.
Begg et al. (1953) investigated the effects of the solid form 
of Walker-256 carcinoma on young male and female rats. They found that 
males, which normally possess higher liver catalase, than females, show a 
greater reduction in liver catalase (66 per cent) than the female rats 
(45 per cent) when supporting an actively growing tumor.
Liver catalase reduction in tumor-bearing hosts does not seem 
to be peculiar to mammals. Adams (1953) studied in similar fashion Rous 
sarcoma in adult chickens and found that tumor-bearing chickens show a 
significant reduction in liver catalase in about 48 hours after injection 
of a large dose of homogenized fresh Rous tumor.
Lucke (1954) studied the effects of a kidney carcinoma of the
O
Leopard frog on liver catalase. He found but half as much liver catalase 
in tumorous frogs as was found in normal untreated animals; while kidney
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catalase was reduced to 34 per cent of the normal value.
In regard to the mechanism of reduction of liver catalase in 
tumor-bearing hosts, two notions exist at the present time. Greenstein 
(1942, 1943) and others «have assumed that liver catalase reduction in 
tumor-bearing hosts may be due to an actual lowering of synthesis of 
liver catalase by a toxic agent liberated from tumor tissue. Likewise, 
Adams (1950), working with mouse sarcoma 37 and obtaining similar results 
to those of Greenstein, interpreted his findings as evidence that the 
tumor exerts its influence by releasing some toxic product into the 
circulation. These interpretations, however, throw no light on the 
mechanism of catalase inhibition.
Nakahara and Fukuoka (1948) and again in 1951 and 1953 
(Fukuoka and Nakahara, 1951, 1953) isolated from human tumor tissues a 
protein-like, heat-stable fraction, which when injected into mice intra- 
peritoneally, caused a marked reduction in their hepatic catalase. These 
authors suggested that the tumor-forming agent may exert its function by 
affecting protein metabolism and, therefore, the synthesis of iron- 
containing protein enzymes (Fukuoka and Nakahara, 1953). Greenfield and 
lleister (1951), using a fraction obtained from mouse mammary tumor, found 
that intraperitoneal injection of such a fraction into normal mice pro­
duced a marked but reversible decrease in their liver catalase activity. 
This effect was noticeable 24 hours after the injection and had disap­
peared in 72 hours. This tumor fraction was also heat-stable as noted 
by Nakahara- Neither group could demonstrate an inhibitory effect of 
this tumor fraction in vitro. Lucke, Berwick and Zeckwer (1952), 
studied the liver catalase activity of parabiotic rats with one partner
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carrying a cumor and found that liver catalase was depressed in both 
animals. They concluded than the catalase-depressing agent from the 
tumor tissue is either elaborated in relatively large amounts by the 
tumor or disappears relatively slowly from the blood stream.
Greenfield and Price (1954) extracted quantitatively the liver 
catalase of tumor-bearing rats and found that there is actually less 
catalase in these animals than in normal rats.
Tschudy and Collins (1957), studying b-amino-levulenic acid 
dehydrase, an enzyme involved in the synthesis of porphobilinogen, in 
tumor-bearing mice found that the variations in concentration of this 
enzyme closely resemble those of liver catalase of the same animals. 
This finding may only suggest the possibility of reduction of catalase 
synthesis in tumor-bearing animals. This, as the authors point out, 
is only a conjecture and should be further investigated.
The second idea considers the lowering of -iver catalase of 
tumor-bearing animals to be due to an inhibition of activity of this 
enzyme by the tumor tissue extract. Hargreaves and Deutsch (1952) 
found that boiled aqueous extract of tumors, and to a lesser extent 
the boiled arueous extract of normal liver and spleen homogenates, 
caused an ̂  vitro inhibition of crystalline catalase. This fraction 
also produced inhibition of other iron-containing enzymes. This in­
hibitory function operates apparently through a reversible combination 
with the iron porphyrin group, since mixtures of catalase and inhibi­
tors absorb much less light (optical density 0.185) at 405 than does 
the catalase (optical density 0.205) alone. Alexander (1957), utiliz­
ing ethanol-soluble boiled aqueous extract of a tumorous rat liver
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homogenate concluded thac the catalase inhibition, is due to autoxidation 
of ascorbic acid and sulfhydryl groups in the extract. The exact mechan­
ism of inhibition caused by tumor extracts in vivo or in vitro still has 
not been established.
In light of these reports, it is clear that many of these authors 
have by inference implicated catalase as a factor in tumorigenesis. The 
problem, as we see it̂  is whether the low liver catalase levels contrib­
ute to tumorigenesis, or whether the progressive growth of the tumor 
produces low liver catalase, or whether there, in fact, exists any caus­
al relationship between the two.
Our recent knowledge of the effect of adrenal gland hormones on 
natural resistance of many species to heterologous tumor transplants 
(Toolan, 1954) and the depressing effects of these hormones on liver 
catalase (Troop and Stanley, 1956) make the consideration of the possi­
ble role of catalase in tumorigenesis not only attractive but impera­
tive.
While the details of study of this problem were being consider­
ed, early in the spring of 1956, the author discovered that a colored 
strain of rats in our laboratory when inoculated with the standard dose 
of ascitic fluid, did not respond to the inoculation by development of 
the tumor. On further challenge, it was found that this group of rats 
was resistant to the solid form as well as to the ascitic form of 
Walker-256 carcinosarcoma. These rats are presumably descendants of 
the captive colony of wild Norway rats propagated by the Wistar Insti­
tute as described by King (1932). Since there has been no report in
O
the literature concerning resistance of this strain of rats to
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Walker-256 carcinosarcoma, the strain was collectively designated OK-R 
(Oklahoma resistant).
The OK-R strain then sef.med to be an invaluable means by which 
the problem of tumorigenesis and tumor resistance could be more thorough­
ly investigated. Although there have been some suggestions in regard to 
liver catalase level and tumorigenesis, (Adams, 1950) no unified study 
has been completed based on this point.
It was then decided to base our study upon the investigation of 
the effects of adrenal steroids on liver catalase and tumorigenesis in 
both resistant and susceptible animals.
With the advent of ascites tumors as a modem tool in experi­
mental cancer research (Warburg, 1956), it was decided that this type 
in preference to the solid form should be employed. The ascitic form 
of Walker-256 carcinosarcoma used in our laboratory produces severe 
synptoms promptly, and thus conveniently establishes a short survival 
time in the infected host (Kitabchi, 1956; Master's thesis).
CHAPTER II 
EXPERIMENTAL PROCEDURES AND RESULTS
The animals used in the first part of these experiments were 
Holtzman albino rats of the same age and sex and were maintained on 
Purina Laboratory Chow and water ad libitum.
The tumor used was the ascitic form of Walker-256 carcino­
sarcoma. Transplantation was effected by withdrawal of ascitic fluid 
from the abdomen of an infected host. The fluid was mixed in vitro with 
an antibiotic^ and subsequently injected intraperitoneally in a standard 
dose of the fluid containing live tumor cells into the new host.
Liver catalase was determined by the perborate method of 
Feinstein (1949). The animals were killed by disjoining the cervical 
vertebrae; the livers were excised and immediately washed in a M/15 phos­
phate buffer solution (pH 6.8), blotted dry and weighed. They were then 
frozen for at least eight hours and were used for catalase assay not 
later than 36 hours after freezing. A two-gram sample of each liver by 
wet weight was taken. Eighteen milliliters of cold buffer solution 
were added to each sample and the mixture was homogenized in a Waring 
blendor for exactly one minute. Three one-ml aliquots of this homogen­
ate were placed in 3 aluminum dishes and their dry weights were
^Terranycin hydrochloride, Chas. Pfizer & Co.
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determined. To the fourth aliquot of the homogenate was added enough 
triply distilled water to make a 1:500 dilution. Of this dilute homo­
genate, 0.3 ml was used for each determination of the liver catalase
activity as follows:
A 1.5 per cent solution of tetrahydrated sodium perborate was 
used as a generator of hydrogen peroxide. This In turn served as sub­
strate for liver catalase. Four 125 ml Erlenmeyer flasks numbered
from 1 to 4 were set up for each determination. Eight ml of cold
sodium perborate solution were placed In each flask and 1.5 ml of 
M/15 phosphate buffer (pH 6.8) was added. The flasks were then 
Immersed In a water bath at 37® C and were incubated for exactly 15 
minutes; at the end of this period, flasks 1 and 4 received 0.5 ml 
of triply distilled water while flasks 2 and 3 received 0.5 ml of 
the 1:500 dilution of liver homogenate. Each flask was then Incubated 
for 5 minutes. The reactions In each flask were then stopped by the 
addition of 10 ml of a solution of 2 N sulfuric acid. The contents of 
each flask were titrated with a standard potassium permanganate solu­
tion. Flasks 1 and 4 served as control blanks. Hydrogen peroxide 
values were then established for all four flasks and those values for 
flasks 2 and 3 were substracted from those for flasks 1 and 4. Thus, 
the amount of perborate that was destroyed by the catalase alone In 
flasks 2 and 3 was determined.
The unit of liver catalase activity was expressed as mllle- 
qulvalents of sodium perborate destroyed per mg dry weight of liver 
tissue.
Troop (1955); utilizing the perborate method of Feinstein
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and a Waring blendor for homogenization of the liver tissue, reported 
the liver catalase activity per gram of wet weight of the tissue.
Since the period of one minute that he used for homogenization of tis­
sue appeared to be too short for complete homogenization, it was 
decided to determine the dry weight of each sample in triplicate and 
report the liver catalase activity per mg dry weight of the tissue.
Studies on Susceptibility in Albino Rats
In order to investigate the nature of susceptibility to Walker- 
256 carcinosarcoma, it was thought that such a study should be focused 
first on the systemic effects of this cumor. For this purpose four 
series of Holtzman albino rats were used. This strain of animals has 
been found to be practically 100 per cent susceptible to both ascitic 
and nodular forms of our experimental tumors.
Series I consisted of 27 mature females, subdivided into 6 
groups, of three animals each, while a seventh group of 9 untreated 
animals served as controls. Each animal in the experimental group re­
ceived 1 ml of ascitic fluid previously treated with antibiotic intra- 
peritoneally, whereas the control animals received 1 ml of isotonic 
saline. Each group was sacrificed at a definite interval following 
tumor implantation. Groups 1, 2, 3, 4, 5, and 6 were sacrificed 2,
4, 6, 8, 10, and 12 days respectively after inoculation with the tumor 
fluid. At the time of autopsy, each liver was rpmoved, washed clear 
of blood in cold phosphate buffer, blotted dry, weighed, and its cata­
lase activity determined as outlined above. Weights of the spleen 
and adrenal glands were also determined. These weights were then
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calculated per 100 grams of body weight and are so reported. The
Q
organs were fixed in a 10 per cent solution of formalin and histo- 
logical sections of the liver, spleen and adrenals were prepared 
and stained with iron hematoxylin and eosin for later study.
The data from the 27 female rats used in this experiment are 
given in Table I. The data in Table I show that mature tumor-bearing 
female rats responded with a small decrease in liver catalase. The 
only significant reduction occurred by the 8th day after injection 
of the tumor and even then there was only a 14 per cent reduction in 
liver catalase.
Since it is known that female rats normally have a lower 
liver catalase than males, (Hargreaves and Deutsch^ 1952), we 
wondered if this small reduction in tumor-bearing females might not 
be due to the initial low catalase level based on a sex difference.
It was, therefore, decided to contrast this finding with a similar 
study in males. For this purpose a second series of rats consisting 
of 6 groups of males were chosen. A group of 12 mature males served 
as controls. The results of this experiment are given in Table II.
It will be noted that mature tumor-bearing male rats showed a greater 
catalase depression by 48 per cent than did the female group. This 
reduction was greatest by the eleventh day after inoculation of the 
tumor fluid.
It has been reported that very little difference exists be­
tween the liver catalase activity of normal immature male and female 
rats. A sex difference in catalase values becomes apparent only as
TABLE I
SYSTEMIC EFFECTS OF WALKER -256 CARCINOSARCOMA ON MATURE FEMALE ALBINO RATS
Sacrificed Number of Gm, Liver Wt. Mg, Adrenal Wt. Mg. Spleen Wr, Liver Catalase 
Days After Animals per 100 gm. per 100 gm. per 100 gm. Activity
a « P 0.05 
b « P V 0.05 y 0.02
Inoculation Body Wt. Body Wt. Body Wt.
2 ;i 3.01 13.9 171 2.21 (± 0.32)a
4 3 2.79 16.3 255 2.13 (± 0.14)a
6 3 3.15 18.4 329 1.89 (± 0.22)a
8 3 3.21 19.1 547 1.93 (± 0.14)b*
10 3 3.29 17.1 680 2.39 (± 0.32)a
12 3 3.06 19.5 619 2.07 (± 0.20)a
Control 9 2.66 15.7 180 2.26 (± 0.28)
*Data assumed to be significant at this level.
NJ
TABLE II





Gm, Liver Wt. 
per 100 gm.
Mg. Adrenal Wt. 
per 100 gm.




Inoculation Body Wt. Body Wt. Body Wt.
3 3 3.01 11.9 223 2.51 (± 0.39)a
6 3 3.13 12.3 357 2.26 (± 0.07)c*
9 3 3.47 15.2 812 2.24 (± 0.49)b*
10 3 3.37 27.1 584 1.15 (± 0.26)e*
11 3 3.10 2,6.2 566 1.00 (± 0.39)e*
12 3 3.24 19.8 601 1.43 (± O.ODe*
Control 12 2.88 10.7 199 2.65 (± 0.48)
*Data assumed to be significant at this level. 0
a ” p\0.05 
b « P(0.05} 0.02




the animals approach maturity (Seabra and Deutsch, 1955).
In the light of the above report, it appeared desirable to study 
catalase values in a series of immature animals of both sexd’s after they 
were inoculated with the ascites tumor. Â total of 31 young females and 
30 young males were used as indicated in Tables III and IV respectively. 
The details for this experiment were similar to those outlined above for 
the adult animals. Tables III and IV show that liver catalase was re­
duced in both immature male and female rats. The cumulative data reveal 
the following results from Tables I-IV and Figures 1-4:
a. Liver catalase activity was decreased in all four groups 
of tumor-bearing rats, although this depression was least in mature 
females.
b. In all four groups of tumor-inoculated rats there was an 
increase in weight of spleen, liver, and adrenal glands. This increase 
was statistically significant when mean absolute values of each organ 
for each group were calculated.
c. The enlargement of the adrenal glands in the mature 
tumor-bearing male rats seemed to be inversely related to the change in 
liver catalase. To determine the significance of such a relationship, 
the Piersonian correlation coefficient (r) was calculated under the 
assumption of linearity between the mean value of liver catalase and the 
mean value of the absolute weight of adrenal glands at each time inter­
val (see Appendices A through D). Only one value of z was found to 
exceed twice the standard error. This occurred in the mature male group 
where there was significant inverse relationship between adrenal weight 
and liver catalase. No such significant relationship seemed to exist
TABLE III
SYSTEMIC EFFECTS OF WALKER 256 CARCINOSARCOMA ON IMMATURE FEMALE ALBINO RATS 
Sacrificed Number of 
Animals
Gm. Liver Wt, 
per 100 gm.
Mg. Adrenal Wt. 
per 100 gm.
Mg. Spleen Wt. Liver Catalase 
per 100 gm. Activity
a « 0.05
b » P< 0.05) 0.02 
e = P^O.OOl
Inoculation Body Wt. Body Wt. Body Wt.
3 4 4.26 32.9 580 1.51 (± O.lDe*
6 5 3.85 28.5 863 1.78 (± 0.20)b*
8 5 4.14 32.2 1577 1.93 (± 0.09)a
10 5 3.98 32.0 962 1.26 (± 0.04)e*
12 5 3.92 35.3 940 1.50 (± 0.21)e*
Control 6 3.21 28.6 240 2.04 (± 0.33)
*Data assumed to be significant at this level.
Ln
TABLE IV
SYSTEMIC EFFECTS OF WALKER-256 CARCINOSARCOMA ON IMMATURE MALE ALBINO RATS
*Data assumed to be significant at this level,
a' « P ” 0.05 
a P >  0.05 






Gm. Liver Wt. 
pe.j: 100 gm. 
Body Wt.
Mg. Adrenal Wt. 
per 100 gm. 
Body Wt.
Mg. Spleen Wt. 




3 5 4.26 19.3 488 2.09 (± 0.22)a
6 5 4.13 15.9 727 2.46 (± 0.30)a
8 5 4.56 16.5 1467 1.79 (+ 0.28)a'*
10 5 3.91 22.1 693 1.29 (+ 0.18)c*
12 5 4.51 17.3 1526 2.32 (+ 0.23)a
Control 5 4.02 14.0 272 2.16 (+ 0.23)
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! Other three groups These results were as follows:
Groups r z S.E.2
Mature Male 0.9608 1.9588 0.578
Immature Male 0.8280 1.1880 0.709
Mature Female 0.1180 0.1186 0.578
Immature Female 0.2520 0.2550 0.709
d. A deterraination of dry weight of spleen, liver, and 
adrenals in the latter part of this experiment revealed that the 
spleens of the tumor-bearing and normal animals had similar values 
for water content. The liver and adrenal glands of the tumorous 
rats were 2.5 and 3.5 per cent higher in water content respectively.
These determinations were performed on a total of ten experimental 
and 5 control animals.
e. When absolute organ weights ?n each group (Appendices 
A through D) were plotted as in Figure 1-4, a strikingly similar 
overall graph was obtained that closely paralleled the changes of the 
relative weights of the organs when calculated per unit of body weight.
Histological studies of liver, spleen and adrenal glands of 
animals with the tumor revealed active foci of hematopoiesis in these 
organs. Hematopoiesis was first detectable, in all of the three 
organs after the rats had carried the tumor for 8 days. Adrenal glands 
of both tumorous males and females showed hematopoietic activity in the 
zona fasciculata. Plates 1, 2, 3, and 4 are photomicrographs of sections 
of these three organs.
Liver catalase activity of all four groups was subjected to 
the "t" test and when values for P were equal to 0.05 or less the
22
Plate 1. Hematopoiesis in liver of tumor-bearing rat (x 163).







Plate 3. Hematopoiesis in adrenal cortex of tumor-bearing rat 
(x 473).









difference was considered to be significant.
The enlargement of adrenal glands has been observed previously 
by Begg (1951) in a group of rats carrying a solid form of this tumor. 
Our study supplements his work by supplying the progressive changes in 
relation to liver catalase.
Other investigators have studied the effects of adrenalectomy 
on growth rate of the solid form of Walker-256 carcinoma (Talalay et 
al., 1952), and on Ehrlich mouse ascites tumor (Watson, 1958). These 
two investigators, however, have reported opposite effects of adrenal­
ectomy on tumor growth. Talalay found that adrenalectomy inhibits the 
growth of the experimental Walker tumor, while Watson found that growth 
of the Ehrlich tumor was stimulated by removal of the adrenals.
A study was, therefore, undertaken to establish: (1) the role 
adrenalectomy on growth rate of the ascitic form of Walker-256 carcino­
sarcoma as estimated by development of ascites, and (2) the role of
adrenalectomy on liver catalase of tumor-bearing rats. For this
• *
experiment three groups of mature animals were used.
Groups 1 and 2 were adrenalectomized and sham operated respec­
tively. Each rat in groups 1 and 2 was injected with 1 ml of the 
ascitic tumor fluid intraperitoneally 4 days after the operation while 
the animals in group 3 served as controls and received 1 ml of isotonic 
saline. Table V gives the results of this experiment. Liver catalase 
of groups 1 and 2 was decreased by 14 and 16 per cent respectively as 
compared to that of the unoperated control group. While these differ­
ences were significant as compared with control values, the adrenal­
ectomized and non-adrenalectomized tumor-inoculated animals showed no
TABLE V
EFFECTS OF ADRENALECTOMY AND TUMOR INOCULATION ON MATURE FEMALE ALBINO RATS
Treatment Number of Cm. Liver Wt. Mg. Adrenal Wt. Mg. Spleen Wt. Liver Catalase
Animals per 100 gm. per 100 gm. per 100 gm. Activity
Body Wt.  Body Wt._____ Body Wt.
Adrenalectomized 5 2.41   224 2.13 (+ 0.16)*
Tumor-Injected o
Sham Operated 4 2.99 22.1 246 2.08 (+ 0.IB)*
Tumor-Injected
Untreated Control 3 2.75 15.9 171 2.48 (+ 0.07)
*Slgnlficant at 0.05 level of probability
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significant: difference in their liver catalase or in the rate of tumor 
growth.
These findings raised the question whether adrenalectomy alone 
would cause any significant change in liver catalase in otherwise normal 
animals. Troop and Stanley (1956) had shown that adrenalectomized rats 
had the same liver catalase values as did the control group. The re­
sult of our own study also confirmed this finding of the above investi­
gators.
The recent reports on the effect of adrenal steroids on resist­
ance to heterologous tumor transplants in rats and hamsters (Toolan, 
1954) along with the inhibitory effect of these hormones on liver 
catalase (Troop and Stanley, 1956) and on growth rate of Ehrlich 
ascites mouse tumor (Watson. 1958) pose the question as to whether 
liver catalase and tumor growth are in fact casually related.
A similar paradox in the reports of the use of cortisone on 
growth rate of tumors exists in the literature (Toolan, 1954; Watson, 
1958). In order to compare our results with those mentioned above, 
our experiment was planned, making use of the Walker ascites tumor.
For the purpose of this experiment, 16 immature male rats were divid­
ed into 4 groups as shown in Table VI. Each rat in group 1 received 
5 mg of cortisone! daily for 13 days prior to tumor inoculation; 
following tumor inoculation, each rat received 2.5 mg of cortisone 
daily for 7 days. Rats in group 2 received the same dose of corti­
sone but without tumor inoculation. Rats in group 3 received









EFFECTS OF CORTISONE ON TUMOR-BEARING MALE ALBINO RATS 
(Four Animals in Each Group)
Gm. Liver Wt. 






Mg. Adrenal Wt. Mg. Spleen Wt. 
per 100 gm. per 100 gm.









Liver Catalase Development of 
Activity Ascites
1.81 (+0.24)* None
1.15 (+0.40)** ascites was present 
at autopsy (7 days)
1.11 (+0.25)** ascites was present 
at autopsy (7 days)
1.98 (+0.10) None
N»vD
* Not significant at 0.05 level of probability,
** Significant at 0.001 level of probability.
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Injections of saline and I ml of tumor fluid on the same day that the 
other two groups were inoculated with the tumor, while rats in group 4 
served as controls and received an equivalent amount of saline instead 
of cortisone. Data in Table VI reveal that although cortisone in the 
amount injected caused a reduction in liver catalase and a decrease in 
adrenal weight, it caused no significant change in the rate of ascites 
development es compared to that of an untreated tumor-bearing control 
group.
Studies on Resistance in OK-R Rats
During the spring of 1956, a number of colored rats were 
brought to this laboratory. Some of these animals were inoculated in 
routine fashion for maintaining the tumor in stock. It was soon dis­
covered that these animals were highly resistant to Walker-256 carcino­
sarcoma in both nodular and ascitic form. These animals have been 
designated OK-R (Oklahoma resistant) as outlined earlier. The OK-R 
strain seemed to be an invaluable tool by which some of the phases of 
tumor resistance in relation to catalase could be studied. A prelimin­
ary study of catalase in these resitant rats showed that their levels 
were higher by 15 per cent than those of the Holtzman albino strain 
(susceptible) in use also In our laboratory. Table VII shows the result 
of this study.
In regard to liver catalase and tumor growth, Greenstein and 
Andervont (1942) showed that in general, the greatest fall in liver 
catalase levels is produced by fast-growing tumors, and in fact, certain 
slow-growing tumors produce little or no change in liver catalase.
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TABLE VII
LIVER CATALASE ACTIVITY OF THE OK-R RATS 
Rat Strain Number of Animals Liver Catalase Activity
OK-R (Resistant) 5 2.36 (+ 0.06)*
Albino (Susceptible) 4 2.05 (+ 0.05)
♦Significant at 0.001 level of probability
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Adams (1950), working with sarcoma 37 and carcinoma 63 in mice suggested 
that a parallelism exists between the initial depression of liver cata­
lase and the resistance of the animal to the tumor. He showed that sar­
coma 37 which grows readily produces a greater catalase depression in 
24 to 48 hours than did carcinoma 63 which is a slow-growing tumor. He 
also pointed out that female mice, which showed less catalase depression 
than the males, appear to be more resistant to tumor growth.
Although resistance to some types of tumor is known to exist in 
some strains of mice (Heston et al.. 1945), no attempt has been made to 
determine the possible relationship between catalase and natural immunity 
to a specific tumor.
One interesting approach to this problem seemed available in 
the use of our resistant strain of animals. It was decided to determine 
whether liver catalase in these animals could be lowered in cortisone and, 
if so, to challenge them with tumor when their liver catalase levels were 
thus reduced. For this experiment three groups of male OK-R and three 
groups of male albino rets were chosen. Group 2 received a pretreatment 
injection of cortisone for 10 days prior to tumor inoculation. The daily 
dose of cortisone was 10 mg injected subcutaneously. After tumor inocula­
tion, the animals received further injections of 5 mg doses every three 
days for the next 12 days. The control group of 9 OK-R adult males (group 
1) received the same dosage of cortisone but with no tumor injection.
Table VIII sets forth the results. It became obvious from this study 
that although cortisone injection caused a significant drop in liver
ocatalase of the OK-R strain, ascites did not develop in these animals 
after they were inoculated with the tumor. Three control albino
TABLE VIII
EFFECT OF CORTISONE ON LIVER CATALASE AND SURVIVAL TIME 
OF THE "OK-R" TUW)R-BEARING MALE RATS
Group Treatment
1 Cortisone (GK-R)
























1 1 . 0
*Slgnlflcant at 0.01 level of probability.
**Slgnlflcant at 0.05 level of probability. 
a**Slgnlflcantly higher than group 4.
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susceptible rats received one Injection of the ascitic fluid. These 
animals died within 9 to 11 days after tumor Inoculation. The OK-R 
rats that were treated with cortisone plus the tumor showed the same 
reduction of liver catalase as did the animals that received cortisone 
alone. This indicates that the tumor exerted no potentiating effect 
in catalase-depression produced by cortisone in the OK-R (resistant) 
animals.
Since cortisone Is also known to inhibit the growth of some 
tumors (Watson, 1958) and since other substances of a non-hormonal 
character have been shown to reduce liver catalase. It was decided to 
use such an agent with the thought in mind that the effect of a reduc­
tion in catalase activity on cumorlgenesis might become apparent.
Amino acids containing sulfur are known to cause ̂  vitro (Ceriotti, 
1957) as well as In vivo (Seabra and Deutsch, 1955) inhibition of liver 
catalase. Cystine apparently causes a 20-25 per cent reduction in 
liver catalase when given in doses of 5 mg per day intraperitoneally 
(Seabra and Deutsch, 1955). This amino acid was selected in this work 
as an in vivo catalase inhibitor.
A total of 42 rats, consisting of 2 series, was selected for 
this study. Series I was composed of 4 groups of susceptible albino 
rats as follows:
Group 1 (5) Saline-injected control
Group 2 (4) Saline-injected and tumor-inoculated
Group 3 (5) Cystine-treated and tumor-inoculated
Group 4 (5) Cystine-treated alone
Series II consisted of 3 groups of twice challenged resistant
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(OK-R) rats and were as follows:
Group 1 (8) Cystine-treated and tumor-inoculated
Group 2 (8) Cystine- treated alone
Group 3 (7) Saline-treated alone
A 5 mg daily intraperitoneal injection of cystine in rats of 
group 3 of series I and group 1 of series II started 6 days prior to 
the tumor inoculation. On the 6th day, 1 ml of ascitic fluid, our 
usual dose for the transplantation of the tumor, was injected into 
these animals and followed by the daily injection of 5 mg of cystine 
for the next 15 days. Group 4 of series I and group 2 of series II 
received only injections of cystine, whereas a separate group in each 
series received an intraperitoneal injection of isotonic saline and 
served as controls. Rats in group 2 of series I received saline in­
jections plus the usual dose of tumor fluid. All animals were then 
sacrificed and their liver catalase activity was determined. Tables 
IX and X show the data on the albino susceptible and OK-R resistant 
animals. Although tumor development caused a significant reduction in 
liver catalase in groups 2 and 3 of series I, cystine caused no signif­
icant decrease in liver catalase of either susceptible or resistant 
rats. The OK-R animals, as usual, did not develop the tumor after 
inoculation while all control animals developed the tumor in the regu­
lar time.
TABLE IX
EFFECT OF CYSTINE ON LIVER CATALASE OF ALBINO RATS
Group Treatment Number of Liver Catalase Activity
Animals ______________________
1 Saline-Injected Control 5 2.32 (+ 0.17)
2 Saline Injected and Tumor-Inoculated 4 1.69 (+ 0.40)**
3 Cystine-Treated and Tumor-Inoculated 5 1.78 (+ 0.45)**
4 Cystine-Treated 5 2.29 (+ 0.12)* ^
*Not Significant at 0.05 level of probability.
**Signlflcant at 0.05 level of probability.
OJ
TABLE X
EFFECT OF CYSTINE ON LIVER CATALASE ACTIVITY OF THE OK-R RATS
Group Treatment Number of Liver Catalase Activity
Animals ______________________
1 Cystine-Treated and Tumor-Injected 8 2.33 (+ 0.16)*
2 Cystine-Treated 8 2.43 (+ 0.27)*
3 Sallne-Injected Control 7 2,25 (+ 0.21)
*Not significant at 0.05 level of probability.
CHAPTER III
DISCUSSION
Several hypotheses have been advanced to explain the cause of 
liver catalase reduction in tumor-bearing animals. The exact mechanism 
of this enzyme depression, however, remains unknown.
Greenstein and Andervont (1943) showed that depression of cata­
lase was not due simply to growing tissue within the host since neither 
pregnancy nor progressive growth of embryonic tissue implants in mice 
caused any change in liver catalase.
It is unquestionably true that a host supporting a fast-growing 
tumor faces a terrific demand for nutritive material. When an animal is 
starved, its liver catalase is depressed. This finding was reported by 
Miller (1947), who concluded that the reduction in catalase was due to 
inanition of the animal. He found that not only was liver catalase de­
pressed in starvation, but that this decrease paralleled the decrease of 
protein in the liver.
Sherman et al. (1950), utilizing tumorous rats carrying the solid 
form of Walker-256 carcinoma showed that the nitrogen content of the liver 
did not change significantly as compared to that of the force-fed control. 
This fact has also been confirmed by Stewart and Begg (1953).
Begg et al. (1953), studied the influence of diet on liver
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catalase activity and found that, (I) rats carrying the solid form of 
Walker-256 carcinoma on an adequate protein diet still lost body weight 
and showed loss of liver catalase and, (2) non-tumorous rats on a low 
protein diet showed an actual loss of carcass weight but retained normal 
catalase values. They concluded that loss of liver catalase in tumor- 
bearing animals is not due to disturbances in body growth or to liver 
enlargement.
In our experiments, as indicated in Tables I through IV, it is 
clear that some small increase in liver weight did occur. Histological 
sections of enlarged livers of rats carrying the ascitic tumor showed 
highly active centers of hematopoiesis as early as the 8th day after 
tumor inoculation (plates 1-2). Liver enlargement may be due to two 
distinct causes: (a) the anemia in the cancerous rats may be re-activating 
one of the embryologie hematopoietic organs, and, (b) as pointed out by 
Yeakel (1948), the enlargement of the liver may be connected with protein 
anabolism in growth of the tumor.
Enlargement of the spleen is a significant finding in tumor- 
bearing rats. Hematopoietic foci were also observed in the spleen of 
animals carrying the tumor for 8 days or longer (plate 3).
Splenomegaly has been reported in mice carrying carcinoma 744 by 
Antopol et al. (1954). The enlargement was noticeable before the tumor 
was palpable and hematopoiesis was also reported by these investigators. 
Dalton (1949) postulated that hematopoiesis was the cause of splenomegaly 
in male and female hamsters bearing a mixed cell sarcoma. Begg (1955) 
has reported enlargement of the spleen in rats carrying the solid form
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of Walker-256 carcinoma. Most investigators agree that the cause of 
spleen enlargement must be due to hematopoiesis. Based on our studies on 
dry weight of the enlarged spleen, liver and adrenal glands there is 
essentially no difference between the percentages of water content of 
these normal organs am.d those of the ascitic rat.
In histological studies of the adrenal glands, foci of hematopoie­
sis in the zona fasciculata were located (plate 4).
Apparently when an animal is in dire enough need of blood cells
all the hematopoietic organs chat are usually active during embryonic
life may resume their role as blood-forming organs during adult life.
Of these organs, the liver and spleen are most prominent. It is interest­
ing, however, that when in this present work an isolated experiment on 
hemoglobin determination was done, it was found that enlargement of the 
spleen preceded both the onset of low hemoglobin values and the produc­
tion of ascites.
From our cinalysis of adrenal weights in relation to liver cata­
lase, it is clearly shown that depression of liver catalase is indeed
inversely related to the weight of the adrenal glands in mature tumor- 
bearing male rats. Since it is also known that any type of stress pro­
duces an increase in weight of adrenal glands and that this may increase 
the secretion of cortical hormones (Selye, 1937). it is probably safe to 
assume at this time that the adrenal glands of mature male rats, which 
normally are smaller than those of the mature female, have undergone an 
extensive enlargement due to a tremendous stress produced by the growth 
of the tumor. Adrenal enlargement in the male tumor-bearing rat seems
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to be greater than that of the ether three groups of rats with the tumor» 
Initial large adrenals in normal females may be due to estrogen secre­
tion (Creep and Jones, 1950). The adrenal glands of these rats may then 
be already stimulated to their physiological maximum.
It is interesting, however, to notice that although the adrenal 
glands in the female rats carrying the tumor did not become much enlarged 
and liver catalase did not change significantly, nevertheless, full asci­
tes developed in every instance. This might indicate that catalase de­
pression is but a secondary factor in host response.
With the fact in mind that adrenalectomy does not affect liver 
catalase of the otherwise normal rat (Troop and Stanley, 1956), we pro­
ceeded to determine the effects of tumor growth on liver catalase of 
adrenalectomized rats. The results of this experiment, as shown in Table 
V, indicate that liver catalase was equally depressed in both adrenalecto­
mized and non-adrenalectomized tumorous animals.
The experiment on the effect of cortisone-treatment on the growth 
rate of this tumor and on liver catalase revealed that although this 
steroid caused a reduction in liver catalase, there was no change in the 
rate of ascites formation. This may indicate that the level of liver 
catalase is not necessarily directly related to tumor development. Al­
though the overall effect of cortisone treatment resulted in low liver 
catalase activity, this result was not statistically significant because 
of large variations in response of different animals.
Cortisone plus tumor-inoculation only gave as much decrease in 




fact that the tumor by itself will lower this enzyme maximally.
The mechanism by which cortisone decreases liver catalase is not 
known. It is known, however, that rats treated with cortisone exhibit 
hypoferemia (Hamilton et al_. (1951). Since catalase is a hame-containing 
enzyme, decrease of iron in the blood may, in some way, cause reduction 
of liver catalase. Cortisone may also exert its effect simply through 
its catabolic action.
While this work was in progress a paper by Troop (1958) presented 
a new hypothesis in regard to the hormonal mechanism of the regulation of 
liver catalase in normal rats. He proposed that liver catalase may be 
controlled by the ratio of mineralocorticoid to glucocorticoid rather 
than by the absolute value of either. If this assumption is correct, 
one may assume that in tumor-bearing rats in which liver catalase is low, 
this ratio may be upset by increased values of glucocorticoids. The loss 
of weight normally present in tumor-bearing rats may then be explained on 
the basis of exaggerated gluconeogenesis due to overstimulation of the 
adrenal cortex. This hypothesis needs to be substantiated.
In the second part of this work, the mechanism for tumor resist­
ance was sought. The first approach to this problem was focused around 
liver catalase activity since in a preliminary study of normal OK-R 
(resistant) animals, a significant 15 per cent higher level in liver 
’catalase was observed. Furthermore, these animals maintained this higher 
value even after being challenged twice with the standard dose of tumor
inoculum. It was found that although cortisone injection caused a sig-
e
nificant decrease in liver catalase of the resistant strain, no tumor
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developed.
It is known that cortisone may exert an inhibitory effect on the 
■growth rate of solid tumors (Watson, 1958). However, our experiment, as 
indicated in Table VII, showed that cortisone exerted no significant 
effect, either stimulation or inhibition on formation of ascites in the 
albino rats. This has also beer indicated in Table VIII (groups 5 and 6).
Injection of cystine into both susceptible, albino and resistant 
OK-R rats caused no significant change in liver catalase. Cystine has 
been reported to be a catalase inhibitor, (Seabra and Deutsch, 1955).
It is assumed that failure of cystine to give catalase depression in our 
experiments may be due to its insolubility in water or saline and, there­
fore, it might not have been injected in sufficient quantity to cause 
depression of liver catalase. In any case, the cystine-injected OK-R 
(resistant) rats did not take the tumor, while the albino (susceptible) 
animals developed the tumor in every case.
The possibility of a natural or acquired antibody in the OK-R rat
was considered as an additional factor in producing resistance in OK-R
animals. Sekla and Barvic (1956) reported the isolation of a strain of
animals resistant to Walker-256 carcinoma among some black and hooded
rats in their colony. This is a different factor from the one present in
our OK-R strain, because the rats in Sekla's colony took the nodular type
of tumor which grew for a few days and regressed later. Their resistance
factor apparently is carried in the blood stream and can be transferred
to susceptible Wistar rats by way of serum injection. A more recent re-
e
port by Sekla (1958) states that their resistance factor is also capable 
of being milk-bome. We have not investigated these possibilities in our
44
animals.
A new, non-specific antibody, designated "properdin" by Pillemer 
(1954) also remains to be investigated. According to Pillemer, rats 
that show a high degree of resistance to parasites in general have a 
higher titre of properdin than any other species studied. It is possible 
that the OK-R rats may have an even greater titre of properdin in their 
serum than do the normal susceptible animals.
From studies on systemic effects of Walker-256 carcinosarcoma in 
susceptible animals, and on the effect of this tumor in the OK-R rat, and 
also in the light of the work of other investigators, a suggestion may 
be offered in regard to tumorigenesis and liver catalase depression.
The development of a tumor may produce such an insult to the host that 
in an attempt to compensate, all homeostatic mechanisms are activated to 
a maximal capacity. This insult is indeed greater than either starvation 
or injury alone. It is rather a result of both. The tumor mass as a 
nitrogen trap (Mider 1951), not only deprives the host of its nutritive 
materials, but it also exerts other debilitating effects, hence a tre­
mendous activation of the defenses of the body ensues. This then may 
bring about, by way of the adrenal cortex, a depression of liver cata­
lase which is still greater than that found in starvation. Liver cata­
lase levels, therefore, may not be directly related to the potentiality 
of a host to develop or to resist a tumor, but the reduction of this 





1. The sys\e#ic effects of l>e ascitic forT of Walker 256 
carcinosarcoma were studied in m^rure and irmator* male and female rats. 
The animals received an initial dose of the :amor fluid and at a certain 
interval they were sacrificed and rheir liver catalase activity deter­
mined. Weights cf adrenals, live', and spleen per 100 grams of body 
weight were calculated.
a. Liver catalase activity was found to decrease in all 
groups of rats. The drop was most noticeable between the 8th to the 12th 
day after tumor inoculation. Tumor-bearing mat.re females showed less 
change in liver catalase than did mature males or immature animals of 
both sexes.
b. The adrenal glands became enlarged beginning on the third 
day after tumor implantation. In mature male groups the increase ir 
absolute weight of adrenals bore a significant inverse relationship to 
the liver catalase activity of the tumor-bearing mature male hosts. Foci 
of hematopoiesis were noted in the zona fasciculata of the adrenal cortex 
of the tumor-bearing rat from the 8th day after implantation until the 
time of autopsy.
c. Liver weight was increased in all animals inoculated with
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the tumor but this increase was of a low magnitude. The liver also 
showed hematopoiesis at about the 8th day after tumor Inoculation.
d. Spleen enlargement was also observed. This increase was 
noticeable in all the four groups of rats. Foci of hematopoiesis were 
also noticeable from the 8th day after tumor inoculation until the time 
of autopsy. Significant enlargement of the spleen in all four groups 
preceded both hematopoiesis and production ascites.
2. Adrenalectomized tumor-bearing rats showed no greater de­
crease in liver catalase than did the adrenalectomized non-inoculated 
animals.
3. Although cortisone injection caused a drop in activity of 
liver catalase, this drop was not statistically significant. Cortisone 
did not change the growth rate of ascites tumor as estimated by the for­
mation of ascites in susceptible animals.
4. A colored strain of rats was found to be resistant to both 
ascitic and nodular forms of Walker-256 carcinosarcoma. This strain has 
been designated OK-R (Oklahoma resistant). In a preliminary study, it 
was found that the OK-R strain showed a significant 15 per cent higher 
liver catalase activity than the susceptible albino strain. The follow­
ing studies were performed to clarify the possible role of catalase in 
relation to tumor resistance in the "OK-R" animals :
a. Cortisone, a known catalase depressing agent, was given to 
the OK-R rats in an attempt to lower the liver catalase. The animals 
were then challenged with the tumor. It was found that even though liver 
catalase was loured in the OK-R rats by 25 per cent, all of the animals
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maintained resistance to the tumor.
b. Cystine, a non-hormonal catalase depressant in the doses 
given, failed to decrease liver catalase of either the susceptible 
albino or the resistant OK R rats.
5. The hypothesis that the reduction of liver catalase of the 
tumor-bearing rat is a primary effect of hormones of the adrenal glands 
is discussed in light of this work and that of others.
6. From, these studies it is concluded that liver catalase 
activity bears no direct relationship to tumorigenesis in the albino 
(susceptible) strain or to resistance in the OK-R (resistant) rats, and 
that cortisone, even though it markedly reduces liver catalase, has no 
effect on resistance in the OK R strain. Cortisone in our hands did 
not inhibit the development of ascites in susceptible animals.
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APPENDIX A
DATA ON SYSTEMIC EFFECTS OF WALKER 256 CARCINOSARCOMA













2 390 10.8 50.0 526 2.20
2 380 11.6 52.0 665 1.89
2 362 11.6 54.8 733 2.54
4 375 11.3 61.9 982 2.11
4 355 9.3 56.0 886 2.13
4 365 10.0 60.8 920 2.14
6 340 11.5 62.0 1276 2.17
6 340 10.2 62.0 1012 1.74
6 345 10.6 64.8 1082 1.75
8 350 11.7 64.9 1862 2.08
8 345 10.5 74.0 2066 1.97
8 325 10.6 56.0 1662 1.74
10 355 11.3 67.0 3034 2.27
10 o 365 11.7 58.4 2545 2.75
10 355 12.4 58.0 1728 2.16
12 360 11.4 78.4 2306 1.95




Days After Final Body Liver Wt. Adrenal Wt. Spleen Wt. Liver 
Inoculation Wt. (gm) (gm) (mg) (mg) Catalase
12 340 9.8 68.8 2227 2.29
Control 355 10.2 42.8 620 2.16
Control 345 9.0 46.0 512 2.17
Control 360 9.3 57.0 771 2.47
Control 345 8.5 60.8 504 2.11
Control 325 8.7 50.0 538 2.35
Control 350 9.7 49.8 735 2.28
Control 350 9.6 64.0 767 2.31
Control 360 9.3 57-0 596 1.73
Control 335 8.9 61.6 591 2.75
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3 335 10.6 37.8 708 2.65
3 355 10.4 46.0 832 2.42
3 335 9.8 37.8 752 2.47
6 425 13.5 46.0 1697 2.19
6 420 12.5 56.0 1596 2.31
6 445 14.4 55.9 1312 2.27
9 380 13.6 57.0 3216 2.20
9 405 13.6 72.8 2838 1.78
9 415 14.4 52.0 3684 2.75
10 375 12.5 88.6 2258 0.88
10 370 14.3 106.0 2494 1.16
10 370 10.8 108.0 1759 1.40
11 410 12.0 93.0 2768 0.97
11 395 12.0 101.0 1861 0.91
11 330 11.0 100.0 1825 1.15
12 350 11.0 82.0 2059 1.43




Days After Final Body Liver Wt. Adrenal Wt. Spleen Wt. Liver 
Inoculation Wt. (gg) (gm) (mg) (mg) Catalase
12 400 12.5 83.2 2327 ---
Control 335 10.2 32.0 689 2.46
Control 345 10.0 33.8 556 1.91
Control 355 10.3 42.0 785 2.35
Control 420 13.6 41.0 748 1.95
Control 420 13.4 45.0 891 2.81
Control 430 13.5 42.1 845 2.44
Control 385 10.4 49.0 890 3.33
Control 405 10.4 42.0 746 2.47
Control 370 10.8 41.0 7 5 3 2.78
Control 395 10.1 41.8 825 2.83
Control 375 10.5 41.0 716 3.05
Control 405 10.5 47.0 767 3.47
APPENDIX C
DATA ON SYSTEMIC EFFECTS OF WAlKER-256 CARCIN0SARO3MA
ON IMMATURE FEMALE RATS
Days After Final Body Liver Wt. Adrenal Wt. Spleen Wt. Liver
sculation Wt. (gm) (Rm) (mg) (mg) Catalase
3 180 8.0 59.0 980 1.61
3 195 8.0 56.0 1400 1.48
3 195 8.1 70.0 • 1110 1.56
3 205 8.9 70.0 1004 1.37
6 215 7.8 64.0 2317 1.98
6 195 7.5 66.6 1702 1.48
6 195 7.5 59.0 1365 1.92
6 215 8.6 59.0 1958 1.74
6 220 8.6 56.0 . 1658 1.80
8 250 10.2 86.0 4000 1.82
8 230 10.5 76.0 4200 1.97
8 255 10.5 71.0 3400 1.92
8 243 9.4 71.2 3950 1.89
8 240 9.7 88.0 3600 2.06
10 245 9.7 84.0 2252 1.14
10 240 9.7 75.0 2737 1.58





Days after Final Body Liver Wt. Adrenal Wt. Spleen Wt. Liver 
Inoculation Wt. (gm) (gm) (mg) (mg) Catalase
10 250 9.9 62.0 2867 1.48
10 240 9.9 77.0 1948 1.31
12 240 10.8 74.0 2823 1.43
12 260 11.5 87.0 2218 1.53
12 255 9.5 82.0 2090 1.68
12 230 9.3 116.0 1312 1.70
12 245 7.1 72.0 3134 1.18
Control 220 7.1 61.0 499 1.87
Control 225 6.5 67.0 523 2.26
Control 250 — - 68.0 520 2.07
Control 220 7.0 53.0 586 2.10
Control 205 6.4 57.5 463 2.04
Control 195 7.1 67.5 544 1.88
APPENDIX D
DATA ON SYSTEMIC EFFECTS OF WALKER-256 CARCINOSARCOMA













3 215 9.5 40.0 1170 2.05
3 250 10.5 45.0 1304 1.90
3 245 10.5 51.0 1180 2.43
3 230 9.8 43.0 1038 2.17
3 230 9.5 47.0 1018 1.91
6 265 11.2 42.0 1795 2.99
6 255 10.5 45.0 1990 2.24
6 270 11’. 5 36.0 1846 2.35
6 255 10.0 40.4 2162 2.46
6 280 47.6 1815 2.30
8 270 12.5 43.0 4100 2.06
8 280 12.3 48.0 4100 1.82
8 “ 295 13.7 43.0 5100 1.82
8 290 12.3 55.0 3038 1.32
8 280 13.7 44.0 4300 1.94
10 285 11.4 62.0 1846 1.86




Days After Final Body Liver Wt. Adrenal Wt. Spleen Wt. Liver
Inoculation Wt. Ĉ m) (am) (ma) (ma) Catalase
10 295 11.0 71.f 1623 0.85
10 310 11.0 74.0 2239 1.00
10 315 13.6 59.0 2725 1.97
12 305 14.0 48.2 4500 2.61
12 315 15.0 62.0 4500 2.07
12 330 14.5 48.1 4900 2.16
12 320 14.5 48.9 4700 2.51
12 305 13.0 43.8 5400 2.26
Control 310 11.9 35.0 748 2.21
Control 310 13.2 54.0 858 2.08
Control 285 11.7 43.0 818 1.95
Control 270 10.0 33.0 842 2.53
Control 240 10.0 34.0 585 2.01
APPENDIX E
DATA ON EFFECTS OF ADRENALECTOMY COMBINED WITH TUMOR












and Tumor 365 8.3 618 2.25
Adrenalectomy 
and Tumor 320 8.3 - — - 880 2.27
Adrenalectomy 
and Tumor 340 8.0 — —— 721 2.10
Adrenalectomy 
and Tumor 373 8.5 “ —- 806 2.09
Adrenalectomy 
and Tumor 290 7.5 — — - 728 1.93
Sham Operation 
and Tumor 350 10.0 74 670 2.13
Sham Operation 
and Tumor 300 10.2 78 830 2.17
Sham Operation 
and Tumor 310 9.1 67 775 1.89
Sham Operation, 
and Tumor 325 9.0 64 861 2.13
Control 365 3.0 52 578 2.46
Control 275 10.0 55 524 2.45
Control 370 9.0 50 605 2.53
59
APPENDIX F
DATA ON EFFECTS OF CORTISONE ON TUMOR-BEARING 
IMMATURE MALE RATS
Treatment Wt. (gm) 
205































































































Final Body Liver Wt. Adrenal Wt. Spleen Wt. Liver
Treatment Wt. (em) (gm) __ (me) (me) Catalase
Control 305 10.3 41.6 669 1.84
Control 260 8.3 42.0 491 2.07
Control 250 8.0 41.8 600 2.03
Control 230 7.7 41.4 392 1.98
APPENDIX G
DATA ON LIVER CATALAoE ACTIVITY OF FEMALE "OK-R" 














DATA ON EFFECTS OF CORTISONE ON LIVER CATALASE AND TUMOR
DEVELOPMENT IN MALE "OK-R" AND MAIE ALBINO RATS
Cortisone (OK-R) 1.49 --
Cortisone (OK-R) 1.73 --
Cortisone (OK-R) 1.98 --
Cortisone (OK-R) 1.97 --
Cortisone (OK-R) 2.04
Cortisone (OK-R) 2.19 --
Cortisone (OK-R) 2.08 -—
Cortisone (OK-R) 1.36 —  —  —
Cortisone (OK-R) 2.18 ------
Cortisone and Tumor (OK-R) 1.16 No ascites formed
Cortisone and Tumor (OK-R) 2.25 No ascites formed
Cortisone and Tumor (OK-R) 2.16 No ascites formed
Cortisone and Tumor (OK R) 1.78 No ascites formed
Cortisone and Tumor (OK-R) 2.38 No ascites formed
Untreated (OK-R) 2.87 ------
Untreated (OK-R) 2.43 —  -  -




















Cortisone and Tumor (Albino)
Cortisone and Tumor (Albino)


























DATA ON EFFECT OF CYSTINE ON LIVER CATALASE 
OF FEMALE ALBINO RATS






Cystine and Turner 1.06
Cystine and Tumor 2.12
Cystine and Tumor 2.12
Cystine and Tumor 1.57
Cystine and Tumor 2.02
Saline and 3umor 1.91
Saline and Tumor , 1.10
Saline and Tumor 1.94











DATA ON EFFECT OF CYSTINE ON LIVER CATALASE 
OF "OK-R" FEMALE RATS









Cystine and Tumor 2.37
Cystine and Tumor 2.57
Cystine and Tumor 2.21
Cystine and Tumor 2.20
Cystine and Tumor 2.26
Cystine and Tumor 2.42
Cystine and Tumor 2.13




Treatment * Liver Catalase Activity
Saline 2.50
Saline 2.26
Saline 2.12
Saline 2.51
Saline 2.31
Saline 1.91
Saline 2.12
